José Eduardo Martinelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
José Eduardo Martinelli has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Juliana Francisca Cecato
Faculdade de Medicina de Jundiai
6 shared publications - Everton Balduino
Faculdade de Medicina de Jundiaí, Brazil
3 shared publications - Ivan Aprahamian
Department of Chemistry Dartmouth College 6128 Burke Laboratory Hanover NH 03755 USA
3 shared publications - Brian Alvarez Ribeiro de Melo
Maringá State University, Brazil
2 shared publications - José Maria Montiel
Universidade São Judas Tadeu
2 shared publications - Daniel Bartholomeu
Unianchieta
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Revista Ibero-Americana de Humanidades, Ciencias e Educacao in Revista Ibero-Americana de Humanidades, Ciências e Educação
- Vol. 12 (10) , 1-11
PERFIL DAS POTENCIAIS INTERAÇÕES MEDICAMENTOSAS EM EVENTOS REGISTRADOS COMO POSSÍVEIS REAÇÕES ADVERSAS EM PESSOAS IDOSAS POLIMEDICADAS
Este estudo teve como objetivo caracterizar as potenciais interações medicamentosas presentes nos registros de possíveis reações adversas a medicamentos (RAM) e descrever as manifestações clínicas documentadas em pessoas idosas polimedicadas. Foram analisados 264 prontuários de pessoas com 60 anos ou mais, em uso contínuo de quatro ou mais medicamentos, atendidas em ambulatório de geriatria entre 1º de janeiro e 30 de junho de 2023. Para o presente recorte, a análise concentrou-se nos 33 eventos de possíveis RAM registrados em 28 participantes no contexto de potenciais interações medicamentosas. As combinações farmacológicas foram avaliadas segundo a classificação de risco empregada no protocolo original e fonte farmacológica complementar; as manifestações foram identificadas a partir dos registros médicos. Não foi aplicado instrumento específico de causalidade. Entre os 33 eventos, as categorias mais frequentes envolveram substratos e inibidores moderados da CYP3A4 (n = 11; 33,3%) e a categoria combinada CYP2C8/9 (n = 6; 18,2%). Tontura (n = 11; 33,3%), cefaleia (n = 4; 12,1%) e problemas urinários (n = 3; 9,1%) foram as manifestações mais frequentes. Os achados descrevem padrões de potenciais interações concomitantes a manifestações clínicas registradas, sem estabelecer relação causal, e podem subsidiar a revisão individualizada da farmacoterapia em pessoas idosas expostas à polimedicação.
- 1 October 2026
- Published by Revista Ibero-Americana de Humanidades, Ciencias e Educacao in Revista Ibero-Americana de Humanidades, Ciências e Educação
- Vol. 12 (10) , 1-11
Open AccessPERFIL DAS POTENCIAIS INTERAÇÕES MEDICAMENTOSAS EM EVENTOS REGISTRADOS COMO POSSÍVEIS REAÇÕES ADVERSAS EM PESSOAS IDOSAS POLIMEDICADAS
Este estudo teve como objetivo caracterizar as potenciais interações medicamentosas presentes nos registros de possíveis reações adversas a medicamentos (RAM) e descrever as manifestações clínicas documentadas em pessoas idosas polimedicadas. Foram analisados 264 prontuários de pessoas com 60 anos ou mais, em uso contínuo de quatro ou mais medicamentos, atendidas em ambulatório de geriatria entre 1º de janeiro e 30 de junho de 2023. Para o presente recorte, a análise concentrou-se nos 33 eventos de possíveis RAM registrados em 28 participantes no contexto de potenciais interações medicamentosas. As combinações farmacológicas foram avaliadas segundo a classificação de risco empregada no protocolo original e fonte farmacológica complementar; as manifestações foram identificadas a partir dos registros médicos. Não foi aplicado instrumento específico de causalidade. Entre os 33 eventos, as categorias mais frequentes envolveram substratos e inibidores moderados da CYP3A4 (n = 11; 33,3%) e a categoria combinada CYP2C8/9 (n = 6; 18,2%). Tontura (n = 11; 33,3%), cefaleia (n = 4; 12,1%) e problemas urinários (n = 3; 9,1%) foram as manifestações mais frequentes. Os achados descrevem padrões de potenciais interações concomitantes a manifestações clínicas registradas, sem estabelecer relação causal, e podem subsidiar a revisão individualizada da farmacoterapia em pessoas idosas expostas à polimedicação.
- Open Access
- 10 August 2026
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 20, 1-8
Effects of a balanced cannabinoid extract on agitation and cognition in older adults with moderate Alzheimer's disease dementia: a randomized clinical trial protocol
Objectives: Alzheimer's disease (AD) is often associated with agitation, which negatively impacts patients' quality of life and increases the burden on caregivers. This protocol aims to investigate the effects of a balanced extract of Cannabis sativa, containing cannabidiol (CBD) and tetrahydrocannabinol (THC), on agitation and cognition in older adults with moderate-stage AD dementia. Methods: Randomized, controlled, prospective, open-label, parallel-group clinical trial lasting three months. A total of 124 participants aged 60 years or older, undergoing geriatric outpatient follow-up, will be included and allocated to two groups: a control group, which will receive the standard of care (SOC), and an intervention group, which will receive SOC plus a balanced extract of Cannabis sativa containing 300 mg CBD and 180 mg THC. The primary outcome will be reduction in agitation, assessed by the Cohen-Mansfield Agitation Inventory. Secondary outcomes include cognition (Addenbrooke's Mini-Cognitive Examination), neuropsychiatric symptoms (Neuropsychiatric Inventory), functionality (Functional Stage Scale and Pfeffer Functional Activities Questionnaire), and adverse events. Placebo control was ruled out for ethical reasons. The study will follow international ethical guidelines, with consent from participants’ legal proxies and supervision by an independent data monitoring committee. The protocol was approved by an ethics committee and registered with ReBEC. Expected results: A reduction in agitation is expected, with possible positive effects on cognition, neuropsychiatric symptoms, and functionality, while maintaining an acceptable safety profile. Relevance: This study may contribute to the use of cannabinoids as an adjunctive strategy in the management of behavioral symptoms of AD dementia in geriatric practice.
- 10 August 2026
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 20, 1-8
Open AccessEffects of a balanced cannabinoid extract on agitation and cognition in older adults with moderate Alzheimer's disease dementia: a randomized clinical trial protocol
Objectives: Alzheimer's disease (AD) is often associated with agitation, which negatively impacts patients' quality of life and increases the burden on caregivers. This protocol aims to investigate the effects of a balanced extract of Cannabis sativa, containing cannabidiol (CBD) and tetrahydrocannabinol (THC), on agitation and cognition in older adults with moderate-stage AD dementia. Methods: Randomized, controlled, prospective, open-label, parallel-group clinical trial lasting three months. A total of 124 participants aged 60 years or older, undergoing geriatric outpatient follow-up, will be included and allocated to two groups: a control group, which will receive the standard of care (SOC), and an intervention group, which will receive SOC plus a balanced extract of Cannabis sativa containing 300 mg CBD and 180 mg THC. The primary outcome will be reduction in agitation, assessed by the Cohen-Mansfield Agitation Inventory. Secondary outcomes include cognition (Addenbrooke's Mini-Cognitive Examination), neuropsychiatric symptoms (Neuropsychiatric Inventory), functionality (Functional Stage Scale and Pfeffer Functional Activities Questionnaire), and adverse events. Placebo control was ruled out for ethical reasons. The study will follow international ethical guidelines, with consent from participants’ legal proxies and supervision by an independent data monitoring committee. The protocol was approved by an ethics committee and registered with ReBEC. Expected results: A reduction in agitation is expected, with possible positive effects on cognition, neuropsychiatric symptoms, and functionality, while maintaining an acceptable safety profile. Relevance: This study may contribute to the use of cannabinoids as an adjunctive strategy in the management of behavioral symptoms of AD dementia in geriatric practice.
- Open Access
- 1 October 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (10) , 864-870
Brief version of the CAMCOG for illiterate older adults with Alzheimer’s dementia
Background: The Cambridge Cognition Examination (CAMCOG) is one of the most used cognitive assessment batteries for older adults. Objective: To evaluate a brief version of the CAMCOG for illiterate older adults (CAMCOG-BILL) with Alzheimer’s dementia (AD) and healthy controls (CG). Methods: Cross-sectional case-control study with 246 illiterate older adults (AD [n=159] and CG [n=87], composed by healthy seniors without cognitive complaints) who never attended school or took reading or writing lessons. Diagnosis of AD was established based on the NIA-AA and DSM-5 criteria. All participants were assessed with the CAMCOG by a researcher blinded for diagnosis. To assess the consistency of the chosen CAMCOG-BILL sub-items, we performed a binary logistic regression analysis. Results: Both the CAMCOG and the CAMCOG-BILL had satisfactory psychometric properties. The area under the curve (AUC) was 0.932 (p<0.001) for the original version of CAMCOG and 0.936 for the CAMCOG-BILL. Using a cut-off score of ≥60 (CAMCOG) and ≥44 (CAMCOG-BILL), both instruments had the same sensitivity and specificity (89 and 96%, respectively). Conclusion: The CAMCOG-BILL may be a preferred tool because of the reduced test burden for this vulnerable subgroup of illiterate patients with dementia.
- 1 October 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (10) , 864-870
Open AccessBrief version of the CAMCOG for illiterate older adults with Alzheimer’s dementia
Background: The Cambridge Cognition Examination (CAMCOG) is one of the most used cognitive assessment batteries for older adults. Objective: To evaluate a brief version of the CAMCOG for illiterate older adults (CAMCOG-BILL) with Alzheimer’s dementia (AD) and healthy controls (CG). Methods: Cross-sectional case-control study with 246 illiterate older adults (AD [n=159] and CG [n=87], composed by healthy seniors without cognitive complaints) who never attended school or took reading or writing lessons. Diagnosis of AD was established based on the NIA-AA and DSM-5 criteria. All participants were assessed with the CAMCOG by a researcher blinded for diagnosis. To assess the consistency of the chosen CAMCOG-BILL sub-items, we performed a binary logistic regression analysis. Results: Both the CAMCOG and the CAMCOG-BILL had satisfactory psychometric properties. The area under the curve (AUC) was 0.932 (p<0.001) for the original version of CAMCOG and 0.936 for the CAMCOG-BILL. Using a cut-off score of ≥60 (CAMCOG) and ≥44 (CAMCOG-BILL), both instruments had the same sensitivity and specificity (89 and 96%, respectively). Conclusion: The CAMCOG-BILL may be a preferred tool because of the reduced test burden for this vulnerable subgroup of illiterate patients with dementia.
- Open Access
Psychometric properties of Cognitive Instruments in Vascular Dementia and Alzheimer's disease: a neuropsychological study
To describe elderly performance in the Bender Gestalt Test (BGT) and to discriminate its score by using types of errors as comparison among healthy controls, Alzheimer’s disease (AD) patients, and vascular dementia (VD) patients. We performed a cross-sectional analysis of 285 elderly individuals of both sexes, all over 60 years old and with more than 1 year of schooling. All participants were assessed through a detailed clinical history, laboratorial tests, neuroimaging, and neuropsychological tests including the BGT, the Cambridge Cognitive Examination (CAMCOG), the Mini-Mental State Examination (MMSE), the Geriatric Depression Scale (GDS), and the Pfeffer Functional Activities Questionnaire (PFAQ). The BGT scores were not used to establish diagnosis. Mean BGT scores were 3.2 for healthy controls, 7.21 for AD, and 8.04 for VD with statistically significant differences observed between groups (p<0.0001). Logistic regression analysis was used to identify the main risk factors for the diagnostic groups. BGT’s scores significantly differentiated the healthy elderly from those with AD (p<0.0001) and VD (p<0.0001), with a higher area under the curve, respectively 0.958 and 0.982. BGT’s scores also showed that the AD group presented 12 types of errors. Types of errors evidenced in the execution of this test may be fundamental in clinical practice because it can offer differential diagnoses between senescence and senility. A cut-off point of 4 in the BGT indicated cognitive impairment. BGT thus provides satisfactory and useful psychometric data to investigate elderly individuals.
Open AccessPsychometric properties of Cognitive Instruments in Vascular Dementia and Alzheimer's disease: a neuropsychological study
To describe elderly performance in the Bender Gestalt Test (BGT) and to discriminate its score by using types of errors as comparison among healthy controls, Alzheimer’s disease (AD) patients, and vascular dementia (VD) patients. We performed a cross-sectional analysis of 285 elderly individuals of both sexes, all over 60 years old and with more than 1 year of schooling. All participants were assessed through a detailed clinical history, laboratorial tests, neuroimaging, and neuropsychological tests including the BGT, the Cambridge Cognitive Examination (CAMCOG), the Mini-Mental State Examination (MMSE), the Geriatric Depression Scale (GDS), and the Pfeffer Functional Activities Questionnaire (PFAQ). The BGT scores were not used to establish diagnosis. Mean BGT scores were 3.2 for healthy controls, 7.21 for AD, and 8.04 for VD with statistically significant differences observed between groups (p<0.0001). Logistic regression analysis was used to identify the main risk factors for the diagnostic groups. BGT’s scores significantly differentiated the healthy elderly from those with AD (p<0.0001) and VD (p<0.0001), with a higher area under the curve, respectively 0.958 and 0.982. BGT’s scores also showed that the AD group presented 12 types of errors. Types of errors evidenced in the execution of this test may be fundamental in clinical practice because it can offer differential diagnoses between senescence and senility. A cut-off point of 4 in the BGT indicated cognitive impairment. BGT thus provides satisfactory and useful psychometric data to investigate elderly individuals.
- Open Access
- 26 September 2019
- Published by Elsevier in International Psychogeriatrics
- Vol. 32 (2) , 191-198
The “SuperAgers” construct in clinical practice: neuropsychological assessment of illiterate and educated elderly
- 26 September 2019
- Published by Elsevier in International Psychogeriatrics
- Vol. 32 (2) , 191-198
Open AccessThe “SuperAgers” construct in clinical practice: neuropsychological assessment of illiterate and educated elderly
- Open Access
- 1 October 2018
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 136 (5) , 390-397
Accuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer’s disease: a cross-sectional study
KEY WORDS: Dementia; Apraxias; Diagnosis, differential; Aged; Mental status and dementia tests
- 1 October 2018
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 136 (5) , 390-397
Open AccessAccuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer’s disease: a cross-sectional study
KEY WORDS: Dementia; Apraxias; Diagnosis, differential; Aged; Mental status and dementia tests
- Open Access
- 1 September 2016
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 10 (3) , 247-250
Brazilian National Anthem presenting as musical hallucination: A case report with 9-year follow-up
Musical hallucination is a type of complex auditory hallucination. Possible etiologies are deafness, psychiatric disorders such as schizophrenia, major depression, use of medication and stress, besides neurologic diseases including epilepsy, stroke and cancer. Uncommon etiologies encompass infectious diseases, metabolic disorders, and sensory deprivation. Although musical hallucinations have a major impact on patients' lives, they have been undervalued and understudied in the literature. We report a case of a 79-year-old woman with musical hallucination (hearing a sung National anthem) without cognitive impairment or hearing loss. The patient had preserved insight of her complaint and responded well to neuroleptics.
- 1 September 2016
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 10 (3) , 247-250
Open AccessBrazilian National Anthem presenting as musical hallucination: A case report with 9-year follow-up
Musical hallucination is a type of complex auditory hallucination. Possible etiologies are deafness, psychiatric disorders such as schizophrenia, major depression, use of medication and stress, besides neurologic diseases including epilepsy, stroke and cancer. Uncommon etiologies encompass infectious diseases, metabolic disorders, and sensory deprivation. Although musical hallucinations have a major impact on patients' lives, they have been undervalued and understudied in the literature. We report a case of a 79-year-old woman with musical hallucination (hearing a sung National anthem) without cognitive impairment or hearing loss. The patient had preserved insight of her complaint and responded well to neuroleptics.
- Open Access
- 11 March 2015
- Published by Universidade Federal do Rio Grande do Sul in Estudos Interdisciplinares sobre o Envelhecimento
- Vol. 20 (3)
ANÁLISE DISCURSIVA DAS REPRESENTAÇÕES SOCIAIS DE IDOSOS SOBRE SUAS TRAJETÓRIAS DE VIDA
O objetivo deste estudo foi identificar e analisar as representações sociais dos idosos sobre as suas trajetórias de vida. Utilizou-se como procedimento metodológico a história oral, sob a perspectiva de trajetória de vida. Foram realizadas entrevistas semiestruturadas com sete idosos entre 65 e 86 anos de idade, participantes de grupos de ensino formal em instituição particular localizada na região oeste da Grande São Paulo. Os idosos foram entrevistados individualmente e os dados foram submetidos à análise utilizando o software IRAMUTEQ. Destacaram-se, entre os temas de análise, cinco tipos de representações sociais na trajetória de vida desses idosos: aprendizagem, respeito, mudanças, família e fatos marcantes. Considerou-se que os idosos possuem forças para sonhar e acreditar no aprendizado contínuo e ininterrupto ao longo da vida. Assim, é necessário o desenvolvimento de propostas interventivas educacionais com propostas inovadoras, respeitando as características singulares da população idosa.
- 11 March 2015
- Published by Universidade Federal do Rio Grande do Sul in Estudos Interdisciplinares sobre o Envelhecimento
- Vol. 20 (3)
Open AccessANÁLISE DISCURSIVA DAS REPRESENTAÇÕES SOCIAIS DE IDOSOS SOBRE SUAS TRAJETÓRIAS DE VIDA
O objetivo deste estudo foi identificar e analisar as representações sociais dos idosos sobre as suas trajetórias de vida. Utilizou-se como procedimento metodológico a história oral, sob a perspectiva de trajetória de vida. Foram realizadas entrevistas semiestruturadas com sete idosos entre 65 e 86 anos de idade, participantes de grupos de ensino formal em instituição particular localizada na região oeste da Grande São Paulo. Os idosos foram entrevistados individualmente e os dados foram submetidos à análise utilizando o software IRAMUTEQ. Destacaram-se, entre os temas de análise, cinco tipos de representações sociais na trajetória de vida desses idosos: aprendizagem, respeito, mudanças, família e fatos marcantes. Considerou-se que os idosos possuem forças para sonhar e acreditar no aprendizado contínuo e ininterrupto ao longo da vida. Assim, é necessário o desenvolvimento de propostas interventivas educacionais com propostas inovadoras, respeitando as características singulares da população idosa.